These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 10901705
1. Phenytoin metabolism by human cytochrome P450: involvement of P450 3A and 2C forms in secondary metabolism and drug-protein adduct formation. Cuttle L, Munns AJ, Hogg NA, Scott JR, Hooper WD, Dickinson RG, Gillam EM. Drug Metab Dispos; 2000 Aug; 28(8):945-50. PubMed ID: 10901705 [Abstract] [Full Text] [Related]
2. P450 2C18 catalyzes the metabolic bioactivation of phenytoin. Kinobe RT, Parkinson OT, Mitchell DJ, Gillam EM. Chem Res Toxicol; 2005 Dec; 18(12):1868-75. PubMed ID: 16359177 [Abstract] [Full Text] [Related]
3. Bioactivation of phenytoin by human cytochrome P450: characterization of the mechanism and targets of covalent adduct formation. Munns AJ, De Voss JJ, Hooper WD, Dickinson RG, Gillam EM. Chem Res Toxicol; 1997 Sep; 10(9):1049-58. PubMed ID: 9305589 [Abstract] [Full Text] [Related]
4. Decreases in phenytoin hydroxylation activities catalyzed by liver microsomal cytochrome P450 enzymes in phenytoin-treated rats. Yamazaki H, Komatsu T, Takemoto K, Saeki M, Minami Y, Kawaguchi Y, Shimada N, Nakajima M, Yokoi T. Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):427-34. PubMed ID: 11259327 [Abstract] [Full Text] [Related]
5. Formation of a dihydroxy metabolite of phenytoin in human liver microsomes/cytosol: roles of cytochromes P450 2C9, 2C19, and 3A4. Komatsu T, Yamazaki H, Asahi S, Gillam EM, Guengerich FP, Nakajima M, Yokoi T. Drug Metab Dispos; 2000 Nov; 28(11):1361-8. PubMed ID: 11038165 [Abstract] [Full Text] [Related]
6. Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. Tang W, Stearns RA, Wang RW, Chiu SH, Baillie TA. Chem Res Toxicol; 1999 Feb; 12(2):192-9. PubMed ID: 10027798 [Abstract] [Full Text] [Related]
7. Cytochrome P450-mediated metabolism of haloperidol and reduced haloperidol to pyridinium metabolites. Avent KM, DeVoss JJ, Gillam EM. Chem Res Toxicol; 2006 Jul; 19(7):914-20. PubMed ID: 16841959 [Abstract] [Full Text] [Related]
8. Metabolic activation of diclofenac by human cytochrome P450 3A4: role of 5-hydroxydiclofenac. Shen S, Marchick MR, Davis MR, Doss GA, Pohl LR. Chem Res Toxicol; 1999 Feb; 12(2):214-22. PubMed ID: 10027801 [Abstract] [Full Text] [Related]
11. Characterization of the human cytochrome P450 forms involved in metabolism of tamoxifen to its alpha-hydroxy and alpha,4-dihydroxy derivatives. Notley LM, Crewe KH, Taylor PJ, Lennard MS, Gillam EM. Chem Res Toxicol; 2005 Oct; 18(10):1611-8. PubMed ID: 16533026 [Abstract] [Full Text] [Related]
17. Detection of cytochrome P4503A (CYP3A) in human hepatic stellate cells. Parola M, Robino G, Bordone R, Leonarduzzi G, Casini A, Pinzani M, Neve E, Bellomo G, Dianzani MU, Ingelman-Sundberg M, Albano E. Biochem Biophys Res Commun; 1997 Sep 18; 238(2):420-4. PubMed ID: 9299524 [Abstract] [Full Text] [Related]
18. Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. Zhu M, Zhao W, Jimenez H, Zhang D, Yeola S, Dai R, Vachharajani N, Mitroka J. Drug Metab Dispos; 2005 Apr 18; 33(4):500-7. PubMed ID: 15640381 [Abstract] [Full Text] [Related]
19. Involvement of multiple cytochrome P450 and UDP-glucuronosyltransferase enzymes in the in vitro metabolism of muraglitazar. Zhang D, Wang L, Chandrasena G, Ma L, Zhu M, Zhang H, Davis CD, Humphreys WG. Drug Metab Dispos; 2007 Jan 18; 35(1):139-49. PubMed ID: 17062778 [Abstract] [Full Text] [Related]